🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well giving abiraterone acetate and prednis...
Status
Unknown
Location
USC Norris Comprehensive Cancer Center
Start Date
2012-09
Trial ID
NCT01685125
Treatments Being Tested
This phase III trial compares the effect of usual treatment of chemotherapy...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2021-01-25
Trial ID
NCT04530565
Treatments Being Tested
Research on the mechanism of dasatinib down-regulates the expression of PD-...
Status
Unknown
Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Start Date
2021-06-20
Trial ID
NCT04991532
The main aim of the present study is to evaluate the clinical efficacy of f...
Status
Completed
Location
Soonchunhyang University Bucheon Hospital
Start Date
2010-03
Trial ID
NCT01004497
Treatments Being Tested
The purpose of this study is to determine whether survival can be prolonged...
Status
Completed
Location
University Of South Alabama / Mitchell Cancer Institute
Start Date
2008-10
Trial ID
NCT00744497
Treatments Being Tested
The purpose of this Phase I/II study is to determine the safety and effecti...
Status
Recruiting
Location
Medical University of South Carolina
Start Date
2022-03-03
Trial ID
NCT05036226
Treatments Being Tested
This is a Phase Ib/IIa open-labeled multi-center trial evaluating the feasi...
Status
Completed
Location
Universitätsklinikum Innsbruck
Start Date
2009-06
Trial ID
NCT00850382
Treatments Being Tested
RATIONALE: Dasatinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
Providence Cancer Center at Providence Hospital
Start Date
2007-03
Trial ID
NCT00410813
Treatments Being Tested
To observe the efficacy and safety of the CEP + Dasatinib + Azacitidine as ...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2023-10-21
Trial ID
NCT07046182
Treatments Being Tested
This phase II trial studies how well pembrolizumab and dasatinib, imatinib ...
Status
Active Not Recruiting
Location
Fairbanks Memorial Hospital
Start Date
2019-06-26
Trial ID
NCT03516279
Treatments Being Tested